BMI over time beats genetics in predicting future obesity

January 08, 2020

The promise of genetic testing is charming doctors and patients who are eager to finally make a dent in rising obesity rates. After all, weighing too much is a risk factor for lots of chronic diseases and greatly affects quality of life, but knowing this hasn't made it easier to reverse the growing tide of obesity around the world.

Although the latest methods of genetic risk profiling can help patients know if they're more susceptible to becoming obese, new research out of the Michigan Medicine Frankel Cardiovascular Center and the Massachusetts General Hospital Cardiovascular Research Center suggests we'd be better off focusing on body mass index (BMI), a measure of weight and height.

"We found fitness is a better predictor than genetics of where your BMI will go over time," says lead author Venkatesh Murthy, M.D., Ph.D., a cardiologist at the Frankel CVC. "Genetics clearly has some influence, but other factors are stronger."

Murthy's new paper in JAMA Cardiology reported a person's BMI measurement from 25 years ago was a better predictor of their current BMI than a polygenic risk score.

"There's been a lot of attention to the idea of using genetic information to understand your risk of obesity or being overweight, and for potential drug development to address those genetic risks," says Murthy, an associate professor of internal medicine and radiology. "We wanted to understand how, if at all, genetic data would add to the information already routinely available in clinic. It turns out, our standard clinical exam, including an assessment of BMI, actually has vastly more information to help guide patient care."

BMI over time was most telling

Alongside senior author Ravi Shah, M.D., from the Massachusetts General Hospital, Murthy's new research evaluated health data from a National Institutes of Health-sponsored study of more than 2,500 young adults from across the United States, who 25 years ago volunteered to participate in a longitudinal study. The data in CARDIA (Coronary Artery Risk Development in Young Adults) was collected between 1985 and 2010 to explore the development of cardiovascular disease.

Murthy, Shah and colleagues used a modern "polygenic risk score" (a composite measure of genetic risk of obesity) to calculate genetic risk of obesity for each person in their subset of the CARDIA study and compare it to the measurements taken during the 25 years of the study.

Baseline BMI in young adulthood explained 52.3% of a person's BMI 25 years later when it was considered in combination with age, sex and history of a parent ever being very overweight. The prediction could explain up to around 80% of BMI variation after following someone's BMI over time, rather than just at baseline and 25 years later.

Those same combinations of age, sex and parental weight history, when considered with a polygenic risk score instead of BMI, were also associated with BMI but in a weaker association that only explained 13.6% of BMI in midlife.

The PRS was also more effective at predicting future BMI in the 1,608 white individuals than the 909 black individuals. Murthy noted there's more genetic data available in European populations for constructing genetic risk profiles, leading to some concern about methodology for determining polygenic risk scores for non-white patients.

Cautions against widespread use of genetic risk scores

Murthy said these data serve as a reminder that human genetics might be interesting in large population studies, but that caution is still needed toward incorporating them when providing clinical care and advice to patients.

However, he acknowledges clinicians are seeing more and more patients who have already purchased a genetic report from a direct-to-consumer company and want to go over it with their doctor. It's important for clinicians to be aware of the strengths and limitations of those direct-to-consumer products, Murthy urges.

He said the rising interest in genetic risk scores also brings up the idea of how incorporating them into clinical practice could change behavior. If someone is told they were born more likely to become obese, for example, how will that change their behavior today or this year, or 25 years down the road? Conversely, will people who learn they're less disposed to obesity become more motivated to lose that stubborn weight that's been difficult to shed?

"We don't know those answers very well yet," Murthy says. "However, some data says, whether based on a real genetic score or not, people may perform better in fitness tests if they're told they're genetically more likely to be fit. And we run a risk of demotivating some people if we tell them the genetics are against them, even though we now know other associations with BMI are stronger than genetics."

The good news is calculating your BMI, which Murthy says is a useful marker for the majority of people who aren't elite athletes, is significantly more affordable than purchasing a genetic test. Physicians should already have weight and height records for their patients over time, Murthy says, and the conversations around modifiable risk factors relating to BMI should already be happening during patient visits.

"Ultimately, while genetic risk may be most important in those individuals with rare inherited causes of obesity, for the majority of the population at risk for becoming obese, universal recommendations like healthy eating and remaining active are important and should be reviewed regularly with your personal physician," Shah says.
Paper cited: "Polygenic Risk, Fitness, and Obesity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study," JAMA Cardiology. DOI: 10.1001/jamacardio.2019.5220

Michigan Medicine - University of Michigan

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to